Dedicated Research and Development Partner for Enhanced Formulation and Innovative Pharmaceutical Dosage Forms

Pensatech Pharma is an R&D service partner providing research and development of enhanced formulation and innovative pharmaceutical dosage forms and is located in Berlin, Germany. The company was founded in 2012 as a spin-off from a world-renown academic Pharmaceutics group at the College of Pharmacy at the Freie Universität Berlin.

Pensatech Pharma’s expertise is dedicated to the solution-oriented design and development of dosage forms for existing and new chemical entities as well as life-cycle management.

Pensatech Pharma offers a full range of formulation development capabilities including preformulation, well-defined feasibility studies, formulation concept studies to support in vivo assessment (PK study), development of enabling formulations for rapid evaluation in the clinic and full development of a wide range of pharmaceutical dosage forms primarily in the fields of oral, parenteral, dermal and ophthalmic drug delivery.

Want to learn more? Please take a look to our general flyer >>

Team

Learn more >>

Facilities 

Learn more >>

Competences

Learn more >>

Careers 

Learn more >>

Our Vision and Mission

  • We believe that any innovation starts with a challenge or unusual idea, however each challenge or idea is worth-while to be explored.

  • We dedicate our expertise to the most challenging research questions requiring the creative and innovative use of science and technology.

  • We believe in utilizing our expertise, breadth of technologies and capabilities to find the right answer for your challenges and ideas.

  • We dedicate our resources to the conversion of the best drug delivery and dosage form into a commercially viable drug product.

  • We believe in data-driven science and creative solutions to truly add value to your challenging and ambitious projects.

  • We dedicate our spirit of true partnership with all our customers to develop together.

Our Approach

  • We have a broad toolbox of technologies and in-depth scientific expertise that we utilise to add value to your challenging and ambitious projects.

  • We believe that each project is unique and deserves the right formulation and dosage form to serve our customers as well as the patients.

  • We are committed to the highest ethical and scientific standards guided by patient safety and data-driven science.

  • We innovate by our experience and capability to advance technology by applying multidisciplinary expertise and science to new research questions.

  • We value our customers and strive to build long-term, trusted relationships by delivering our promise on the projects rapidly and with high flexibility to customers’ specific needs.

Pensatech Pharma Team

Prof. Dr. Roland Bodmeier

Managing Director

Prof. Bodmeier is a founder of Pensatech Pharma and acts as Managing Director. He is an expert on innovative drug delivery systems with controlled drug release (peroral systems, pulsatile delivery, micro-, nano-encapsulation, parenteral depot formulations including biodegradable implants and microparticles) and on the delivery of poorly soluble drugs (various nano carriers, lipid-based carriers, (amorphous) solid solutions and dispersions). Prof. Dr. Roland Bodmeier is Professor of Pharmaceutical Technology at the College of Pharmacy at the Freie Universität Berlin, Germany. He served as an Assistant/Associate Professor at the College of Pharmacy at the University of Texas (Austin) (1986-1994).

Prof. Bodmeier studied Pharmacy at the Ludwig-Maximilians Universität München (Germany), received a Ph.D. in Pharmaceutics at the University of Texas at Austin (USA) (1986) and a Dr. rer. nat. habil from the University of Regensburg (Germany) (1993).

Dr. Martin Körber

Director Research & Development

Dr. Körber heads the R&D activities at Pensatech Pharma. He is an expert in the rational design of conventional and complex drug products for oral, topical and parenteral dosage forms as well as in the definition/ control of their quality attributes. Dr. Körber joined Pensatech Pharma in 2013.

Dr. Körber has worked as a senior research scientist at the Freie Universität Berlin on the characterization of controlled release products and the understanding of their manufacturing processes and for B. Braun Melsungen AG (Germany) with responsibilities for the pharmaceutical development of drug-eluting angioplasty products, related method and product validations and regulatory approval aspects.

Dr. Martin Körber studied Pharmacy at and holds a doctorate degree in Pharmaceutical Technology from the Freie Universität Berlin (Germany) (2007).

Prof. Dr. Philippe Maincent

Director of Regulatory Affairs

Prof. Maincent has worked with Pensatech Pharma since 2012 and, in addition to scientific advising, is responsible for Regulatory Affair.

Prof. Maincent has worked with the French National Agency for the Safety of Medicines and Health Products as expert for pharmaceuticals parts of the marketing authorization application (1994-2003), as Vice-President of the Marketing Authorization Committee, President of the Pharmaceutical Working Group and President of the Generic Working Group (2003-2007), as a member of the Marketing Authorization Committee, Pharmaceutical Working and Generic Working Group (2007-2012) and as external assessor (2013-2018). His research focused on drug delivery systems with emphasis on controlled release, polymers, micro- and nanoencapsulation, drug targeting and oral delivery of macromolecules.

Prof. Maincent is Emeritus Professor of Pharmaceutics at the College of Pharmacy at the Université de Lorraine (France). Prof. Maincent studied Pharmacy at the Université de Rennes (France), received a Ph.D. in Pharmaceutical Sciences at the Université Paris-Saclay (France) and a Habilitation from the Université de Lorraine (France).

Dr. Mathias Walther

Co-Founder & Advisor

Dr. Walther co-founded Pensatech Pharma in 2012 and advises Pensatech Pharma on various aspects of product development. Dr. Walther has over 25 years working experience in the design and development of complex oral dosage forms. Following post-doctoral research at Cambridge University (UK) he joined Pfizer Ltd (UK) in 1998. During 13 years at Pfizer, he delivered projects across a variety of drug delivery and formulation areas from early development to commercial production and life-cycle-management. In addition, responsibilities included working with internal and external partners to establish innovative drug delivery technologies and reducing them to routine practice.

Dr. Mathias Walther is a chemist by training and holds a doctorate degree in polymer chemistry from Albert-Ludwig-Universität Freiburg (Germany) (1996).

Dr. Katharina Pail

Manager Research & Development 

Dr. Pail’s expertise is in the areas of innovative drug delivery systems (e.g., nanocarriers, microparticles, parenteral depot and ophthalmic formulations) and formulation-accompanying analytical method development. Dr. Pail joined Pensatech Pharma in 2018.

Dr. Pail studied Life Science Engineering (B.Sc, M.Sc.) at the HTW Berlin, University of Applied Sciences (2018) and holds a Ph.D. in Pharmaceutical Technology from the Freie Universität Berlin (Germany) (2022).

Katharina Bodmeier

Manager Operations & Business Development

Katharina Bodmeier supports the company in all business aspects, including market studies, marketing activities and business development. After internships at various pharmaceutical institutions (USA and China) and several years of marketing experience at a major German E-Commerce company, she joined Pensatech Pharma in 2022.

Katharina Bodmeier studied Economics at the Freie Universität Berlin (Germany) (B.Sc., 2015) and holds a M.Sc. degree in Business Administration with a focus on Marketing from the Christian-Albrechts-Universität zu Kiel (Germany) (2019).

Facilities

Pensatech Pharma operates at two locations in Berlin.  The main laboratory and office is located at Kelchstr. 31, 12169 Berlin, with focus on formulation and analytical development and capabilities to handle narcotics.

In 2014, Pensatech Pharma rented additional laboratory space at Berlin Adlershof, Germany’s leading technology park. These GMP-certified laboratories are authorised to do quality control testing (physicochemical and pharmaceutical analysis) as well as batch certification of finished products and investigational medicinal products. The laboratory includes containment facilities to handle cytotoxic and highly potent APIs.

Site 1: Kelchstr. 31, 12169 Berlin

Site 2: Volmerstr. 7b, 12489 Berlin

Competences

Long experience in the development of challenging drug substances into various dosage forms together with well-equipped facilities enable Pensatech Pharma to deliver R&D solutions rapidly and with high flexibility to the specific needs of our customers.

Our deep scientific understanding of APIs, excipients, formulation science and manufacturing processes enables us to deliver creative solutions to overcome formulation challenges and turn ideas into robust innovative products.

Why Pensatech Pharma?

We believe that each project is unique and that no single formulation approach or technology solves all problems. Our successful collaborations are based on a clear, shared understanding of mutual expectations and outcomes.

Our strategy is to apply our expertise across a wide range of dosage forms and drug delivery technologies to address each specific formulation or dosage form challenge through science and data.

We provide our customers with a rational selection of an appropriate formulation approach for their needs considering API properties, physiological goals, commercial opportunities and intellectual property.

We deliver projects rapidly and with high flexibility to customers’ specific needs, leveraging our years of experience in the development of various advanced formulation and dosage forms for challenging drug substances and in our well-equipped facilities.

We believe that formulation science is data-driven. Our extensive internal data sets covering material science on API and excipients as well as formulation and process science enable us to use predictive modelling in delivering creative and innovative product solutions.

We value our customers and strive to build long-term, trusted relationships by delivering our promise on each project and beyond.

Our strengths include

  • In-depth scientific knowledge and broad expertise with creative problem solving across a wide range of different drug delivery technologies
  • Predictions of dosage form performance based on experience and internal data sets
  • Competence and experience in commercial product development according to the Quality-by-Design framework and industrial requirements
  • Efficient drug-sparing Design of Experiments in formulation development by performing experiments at the right, miniaturised scale
  • Flexible, responsive and rapid development collaborations with dedicated project management
  • State-of-the-art equipment
  • Network of experts and partners across the pharmaceutical industry and academia

Our quality policy​

  • Provide high quality and timely formulation design and development services that consistently meet the requirements and expectations of our customers​
  • Ensure the quality of the analyzed products such that they are suitable for their planned use and comply with applicable approval requirements
  • Continually improve the effectiveness of both the quality management system and the provision of all our services
  • Ensure all staff are trained and briefed about all the quality documentation so that they can implement the policies and procedures in their work ​​
  • Comply with all relevant legislation
  • Pensatech Pharma‘s quality management system is EU-GMP conform and ISO 9001:2015 compliant. We are committed to deliver quality to our customers​. 

Careers

We are constantly looking for talented, focused people who enjoy challenges in a busy work environment and we are always interested in meeting individuals who are looking for new opportunities in areas such as formulation design, analytical chemistry, process engineering, material science and drug delivery.